🇨🇦 Intermitent dosing as per SMPC in Canada

Intermitent dosing as per SMPC (Intermitent dosing as per SMPC) regulatory status in Canada.

Marketing authorisation

Intermitent dosing as per SMPC in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Intermitent dosing as per SMPC approved in Canada?

Yes. Health Canada has authorised it.

Who is the marketing authorisation holder for Intermitent dosing as per SMPC in Canada?

Ivan Šitum, MD is the originator. The local marketing authorisation holder may differ — check the official source linked above.